Multispecific yet truly natural antibodies

Taking next generation, multispecific antibody technologies into Alzheimer’s Disease and Antimicrobial Resistance

Taking next generation, multispecific antibody technologies into Alzheimer’s Disease and Antimicrobial Resistance

Who we are
Who we are

Long term pharma and biotech professionals with a track record of leading projects from research into the market

Our antibody development roots go deep

Read more
Our focus
Our focus

Multispecific yet natural

Alzheimer’s Disease and Antimicrobial Resistance

Read more
CD47 Dual targeting
Our pipeline

Fully human bi- and multi-specific antibodies for the treatment of Alzheimer’s Disease and Antimicrobial Resistant infections

Safe and selective blockade of CD47 on tumors

Read more
Looking into the future
Looking into the future

Beyond bispecific antibodies

Beyond bispecific antibodies

Read more
previous arrow
next arrow

News

Zugriffe: 12565

Read the latest news about discoveric bio group

discoveric bio group – Launch of Website

discoveric bio group – Launch of Website

Verfasst am

The discoveric bio group is excited to be launching today the all new company website and branding.

Read more

TM & © discoveric bio group. All rights reserved.
webdesign byhosted climate friendly